Where's it on?
FDA · Drugs ·

Trokendi XR, (topiramate) extended-release capsules recall

Supernus Pharmaceuticals, Inc. recalled Trokendi XR, (topiramate) extended-release capsules on September 9, 2026 because of failed dissolution specifications. It was sold nationwide.

Why it was recalled

Failed dissolution specifications.

What's recalled

Trokendi XR, (topiramate) extended-release capsules, 50 mg, 30 Capsules, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391 USA, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850 USA, NDC 17772-102-30.

Quantity: 11304 bottles

What to do

Check whether you have the product (match the lot numbers, dates or codes in the official notice). Stop using it, and return it or throw it away as the notice says.

Read the official FDA notice